• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期前列腺腺癌患者的人类白细胞抗原亚型分析

Human leukocyte antigen subtype analysis in patients with advanced adenocarcinoma of the prostate.

作者信息

Akdaş A, Türkeri L, Alican Y, Simşek F, Akoğlu T

机构信息

Department of Urology, Marmara University School of Medicine, Istanbul, Turkey.

出版信息

Prostate. 1994;24(3):111-3. doi: 10.1002/pros.2990240302.

DOI:10.1002/pros.2990240302
PMID:7509482
Abstract

Human leukocyte antigens (HLA) are cell surface glycoproteins that have a significant role in the immune system. In some cancers, changes in major histocompatibility complex (MHC) class I and II expression, usually a reduction or loss of these molecules, appear to provide a mechanism whereby tumor cells may escape host immunity. HLA analysis in patients with advanced adenocarcinoma of the prostate revealed the antigens with the highest relative risk factors as DRw52, DRw53, Bw73, DR2, and B5(51). As a result, determination of HLA haplotypes may prove to be useful in determining the men with a higher risk of developing prostate cancer.

摘要

人类白细胞抗原(HLA)是细胞表面糖蛋白,在免疫系统中发挥重要作用。在某些癌症中,主要组织相容性复合体(MHC)I类和II类分子表达的变化,通常是这些分子的减少或缺失,似乎为肿瘤细胞逃避宿主免疫提供了一种机制。对晚期前列腺腺癌患者的HLA分析显示,相对风险因素最高的抗原为DRw52、DRw53、Bw73、DR2和B5(51)。因此,确定HLA单倍型可能有助于确定患前列腺癌风险较高的男性。

相似文献

1
Human leukocyte antigen subtype analysis in patients with advanced adenocarcinoma of the prostate.晚期前列腺腺癌患者的人类白细胞抗原亚型分析
Prostate. 1994;24(3):111-3. doi: 10.1002/pros.2990240302.
2
Evaluation of human leukocyte antigen expression in patients with prostate cancer.前列腺癌患者人类白细胞抗原表达的评估。
Scand J Urol Nephrol. 2000 Dec;34(6):352-4. doi: 10.1080/003655900455413.
3
Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer.
Cancer Immun. 2003 Feb 14;3:2.
4
Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma.人类白细胞抗原-G(HLA-G)信使核糖核酸和蛋白质在正常人类前列腺组织及前列腺腺癌中的差异表达
J Reprod Immunol. 2006 Aug;71(1):75-86. doi: 10.1016/j.jri.2006.01.006. Epub 2006 Apr 17.
5
Expression of HLA-like structures on a permanent human tumor line PC-93.HLA 样结构在永久性人类肿瘤细胞系 PC-93 上的表达
Tissue Antigens. 1983 Mar;21(3):227-32. doi: 10.1111/j.1399-0039.1983.tb00162.x.
6
Human leukocyte A and B antigens in patients with prostatic adenocarcinoma.前列腺腺癌患者的人类白细胞A和B抗原
J Urol. 1980 Dec;124(6):847-8. doi: 10.1016/s0022-5347(17)55694-3.
7
Altered pattern of major histocompatibility complex expression in renal carcinoma: tumor-specific expression of the nonclassical human leukocyte antigen-G molecule is restricted to clear cell carcinoma while up-regulation of other major histocompatibility complex antigens is primarily distributed in all subtypes of renal carcinoma.肾癌中主要组织相容性复合体表达模式的改变:非经典人类白细胞抗原-G分子的肿瘤特异性表达仅限于透明细胞癌,而其他主要组织相容性复合体抗原的上调主要分布于肾癌的所有亚型中。
Am J Pathol. 2003 Feb;162(2):501-8. doi: 10.1016/S0002-9440(10)63844-8.
8
Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.晚期前列腺病变形态学不同区域中1号染色体和10号染色体位点的杂合性缺失及微卫星不稳定性
J Urol. 2001 Nov;166(5):1931-6.
9
Leukocyte migration inhibition assay in patients with prostate adenocarcinoma.前列腺腺癌患者的白细胞迁移抑制试验
Prostate. 1981;2(2):121-31. doi: 10.1002/pros.2990020202.
10
Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines.恒定链对人乳腺癌细胞系上主要组织相容性复合体I类分子表达及稳定性的影响。
Cancer Immunol Immunother. 2009 May;58(5):729-36. doi: 10.1007/s00262-008-0595-1. Epub 2008 Oct 1.

引用本文的文献

1
Relationship between HLA-DR antigen and HLA-DRB1 alleles and prostate cancer in Japanese men.
Int Urol Nephrol. 1999;31(3):343-9. doi: 10.1023/a:1007126219791.